An EGFP-marked Recombinant Lactobacillus Oral Tetravalent Vaccine Constitutively Expressing Α, Ε, Β1, and Β2 Toxoids for Clostridium Perfringens Elicits Effective Anti-Toxins Protective Immunity
Virulence - United States
doi 10.1080/21505594.2019.1653720
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Informa UK Limited